Table 2.

Benchmarks for hepatitis C virus testing and linkage to care during the Hepatitis Testing and Linkage to Care (HepTLC) initiative, 25 U.S. programs, October 2012–September 2014^a

^aThe HepTLC initiative promoted viral hepatitis B and hepatitis C screening, posttest counseling, and linkage to care at 34 U.S. sites, including 25 programs for hepatitis C testing in Arizona, California, Colorado, Illinois, Maine, New York, North Carolina, Pennsylvania, Puerto Rico, South Carolina, Texas, Virginia, Washington, Washington (DC), and Wisconsin.

^bIncludes 57,570 participants who received an anti-HCV test and 7,146 participants who received an HCV RNA test without first obtaining an anti-HCV test.

^cThere was no goal for this measure.

^dBased on the 57,570 participants who received an anti-HCV test

anti-HCV = HCV antibody

HCV = hepatitis C virus

RNA = ribonucleic acid

NA = not applicable